Ilmarinen Mutual Pension Insurance Co Sells 3,500 Shares of CME Group Inc (NASDAQ:CME)

This post was originally published on this site

Ilmarinen Mutual Pension Insurance Co cut its holdings in CME Group Inc (NASDAQ:CME) by 4.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 83,000 shares of the financial services provider’s stock after selling 3,500 shares during the period. Ilmarinen Mutual Pension Insurance Co’s holdings in CME Group were worth $13,887,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. BlackRock Inc. grew its position in CME Group by 2.4% during the second quarter. BlackRock Inc. now owns 27,282,937 shares of the financial services provider’s stock worth $4,434,567,000 after buying an additional 637,407 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of CME Group by 0.7% in the second quarter. Bank of New York Mellon Corp now owns 3,462,229 shares of the financial services provider’s stock worth $562,750,000 after purchasing an additional 23,030 shares during the period. Bank of America Corp DE increased its position in shares of CME Group by 5.1% in the second quarter. Bank of America Corp DE now owns 2,768,873 shares of the financial services provider’s stock worth $450,053,000 after purchasing an additional 133,177 shares during the period. California Public Employees Retirement System raised its stake in CME Group by 5.4% in the second quarter. California Public Employees Retirement System now owns 2,706,628 shares of the financial services provider’s stock valued at $439,935,000 after purchasing an additional 137,684 shares in the last quarter. Finally, Thornburg Investment Management Inc. lifted its position in CME Group by 3.5% during the second quarter. Thornburg Investment Management Inc. now owns 1,984,234 shares of the financial services provider’s stock worth $322,517,000 after purchasing an additional 66,440 shares during the period. 84.24% of the stock is currently owned by institutional investors and hedge funds.

CME opened at $152.28 on Tuesday. CME Group Inc has a fifty-two week low of $131.80 and a fifty-two week high of $225.36. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $54.05 billion, a price-to-earnings ratio of 21.97, a PEG ratio of 11.32 and a beta of 0.37. The company’s 50 day moving average price is $165.22 and its two-hundred day moving average price is $172.24.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 28th. The financial services provider reported $1.38 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.41 by ($0.03). CME Group had a return on equity of 9.22% and a net margin of 43.68%. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the previous year, the firm earned $1.90 earnings per share. As a group, equities research analysts predict that CME Group Inc will post 6.76 EPS for the current year.

In other CME Group news, Director Daniel R. Glickman sold 900 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $173.22, for a total transaction of $155,898.00. Following the sale, the director now directly owns 14,405 shares of the company’s stock, valued at approximately $2,495,234.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martin J. Gepsman sold 5,000 shares of the company’s stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $173.52, for a total transaction of $867,600.00. Insiders have sold a total of 15,900 shares of company stock worth $2,695,838 over the last three months. Insiders own 1.20% of the company’s stock.

Several brokerages have recently commented on CME. Credit Suisse Group boosted their target price on shares of CME Group from $170.00 to $177.00 and gave the company a “neutral” rating in a research report on Thursday, September 10th. BidaskClub cut shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Wednesday, October 28th. Oppenheimer restated a “buy” rating on shares of CME Group in a research report on Wednesday, July 29th. Bank of America dropped their target price on shares of CME Group from $194.00 to $180.00 and set a “neutral” rating for the company in a research report on Friday, July 10th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of CME Group from $181.00 to $167.00 and set a “buy” rating for the company in a research report on Thursday, October 29th. Five equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $182.29.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Marijuana Stocks

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.